Where Will Salesforce Stock Be in 5 Years?
Salesforce (NYSE: CRM) just turned in a quarter that, on…
Sell
23
CYJBF Quote, Financials, Valuation and Earnings
Last price:
$51.43
Seasonality move
:
-12.36%
Day range:
$51.43 - $51.43
52-week range:
$51.43 - $83.59
Dividend yield:
7.04%
P/E ratio:
2.96x
P/S ratio:
1.51x
P/B ratio:
2.99x
Volume:
--
Avg. volume:
--
1-year change:
-37.09%
Market cap:
$3.3B
Revenue:
$1.8B
EPS (TTM):
$17.39
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Hiab has -- downside to fair value with a price target of -- per share.
CYJBF vs. S&P 500
-
Over the past 5 trading days, Hiab has underperformed the S&P 500 by -1.84% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Hiab does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Hiab revenues have been falling on a year-over-year basis for 9 quarters in a row. In the most recent quarter Hiab reported revenues of $433M.
Earnings Growth
-
Hiab earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Hiab reported earnings per share of $0.87.
Enterprise value:
3.2B
EV / Invested capital:
--
Price / LTM sales:
1.51x
EV / EBIT:
12.32x
EV / Revenue:
1.44x
PEG ratio (5yr expected):
0.01x
EV / Free cash flow:
7.26x
Price / Operating cash flow:
7.63x
Enterprise value / EBITDA:
5.90x
Gross Profit (TTM):
$611.1M
Return On Assets:
36.28%
Net Income Margin (TTM):
51.05%
Return On Equity:
83.64%
Return On Invested Capital:
65.77%
Operating Margin:
15.99%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $4B | $2.3B | $2.2B | $450.2M | $433M | |
| Gross Profit | $832.1M | $601.7M | $611.1M | $136M | $137M | |
| Operating Income | $201.8M | $279.8M | $272.2M | $66.7M | $69.2M | |
| EBITDA | $303.8M | $403.8M | $536.5M | $94.3M | $85.1M | |
| Diluted EPS | $1.27 | $4.70 | $17.39 | $1.37 | $0.87 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $2.4B | $2.5B | $2.9B | $3.6B | $2.1B | |
| Total Assets | $4.6B | $4.6B | $4.6B | $4.7B | $2.7B | |
| Current Liabilities | $1.9B | $1.6B | $2.1B | $2.4B | $1.3B | |
| Total Liabilities | $3.1B | $2.9B | $3B | $2.7B | $1.6B | |
| Total Equity | $1.5B | $1.7B | $1.6B | $1.9B | $1.1B | |
| Total Debt | $1.4B | $1B | $925.2M | $404.3M | $292.8M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $272.8M | $614.9M | $435.5M | $173.5M | $93.6M | |
| Cash From Investing | -$2M | -$62.4M | -$7.1M | -$14.1M | -$3.4M | |
| Cash From Financing | -$144.3M | -$276.7M | -$317.4M | -$134M | -$114.3M | |
| Free Cash Flow | $272.8M | $614.9M | $435.5M | $173.5M | $93.6M | |
CYJBF
Sector
Market Cap
$3.3B
$602.8M
Price % of 52-Week High
61.52%
77.23%
Dividend Yield
7.04%
0%
Shareholder Yield
10.5%
2.32%
1-Year Price Total Return
-37.09%
-3.86%
Beta (5-Year)
0.570
0.777
Dividend yield:
7.04%
Annualized payout:
$2.33
Payout ratio:
13.39%
Growth streak:
2 years
Technicals
8-day SMA
Sell
Level
$51.43
200-day SMA
Sell
Level
$51.43
Bollinger Bands (100)
Sell
Level
51.43 - 51.43
Chaikin Money Flow
Sell
Level
-157
20-day SMA
Sell
Level
$51.43
Relative Strength Index (RSI14)
Sell
Level
2.65
ADX Line
Neutral
Level
32.11
Williams %R
Buy
Level
-97.3529
50-day SMA
Sell
Level
$51.43
MACD (12, 26)
Sell
Level
0.00
25-day Aroon Oscillator
Sell
Level
0
On Balance Volume
Neutral
Level
20.6K
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (3.3044)
Sell
CA Score
(Annual)
Level (-0.4089)
Buy
Beneish M-Score
(Annual)
Level (-4.133)
Sell
Momentum Score
Level (3)
Buy
Ohlson Score
Level (-1.3863)
Buy
Piotroski F Score
(Annual)
Level (8)
Sell
Quality Ratio Score
Level (3)
Buy
Fundamental Score
Level (8)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Cargotec Oyj provides cargo and load handling solutions. Its product portfolio consists of a wide range of handling equipment and solutions, including services for terminals and distribution centers, spare parts for on-road delivery, and systems for handling marine cargo. Mobile equipment mixed with automation and energy-efficient offerings helps customers integrate different handling processes. Cargotec operates three business segments: Kalmar, Hiab, and MacGregor. The majority of sales derive from distributing products, but a global network offers services and components. Customers range from small businesses to large national organizations. The company has established customer relationships in Europe/Middle East/Africa, Asia-Pacific, and the Americas.
Stock Forecast FAQ
In the current month, CYJBF has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The CYJBF average analyst price target in the past 3 months is --.
-
Where Will Hiab Stock Be In 1 Year?
According to analysts, the consensus estimate is that Hiab share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Hiab?
Analysts are divided on their view about Hiab share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Hiab is a Sell and believe this share price will rise from its current level to --.
-
What Is Hiab's Price Target?
The price target for Hiab over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is CYJBF A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Hiab is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of CYJBF?
You can purchase shares of Hiab via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Hiab shares.
-
What Is The Hiab Share Price Today?
Hiab was last trading at $51.43 per share. This represents the most recent stock quote for Hiab. Yesterday, Hiab closed at $51.43 per share.
-
How To Buy Hiab Stock Online?
In order to purchase Hiab stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
2 Ultra Safe Dividend Stocks to Buy Now
Historically, blue-chip dividend stocks have been good choices for periods…
Where Will Asana Stock Be in 5 Years?
Asana stock hasn’t given many investors on Wall Street any…
Stock Ideas
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Buy
65
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Sell
31
REGN alert for May 31
Regeneron Pharmaceuticals [REGN] is down 19.04% over the past day.
Buy
55
RGC alert for May 31
Regencell Bioscience Holdings [RGC] is up 16.13% over the past day.
Sell
42
AMBA alert for May 31
Ambarella [AMBA] is down 15.13% over the past day.
